<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02730143</url>
  </required_header>
  <id_info>
    <org_study_id>REB15-2709_V1</org_study_id>
    <nct_id>NCT02730143</nct_id>
  </id_info>
  <brief_title>Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders</brief_title>
  <official_title>Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective interventional trial in lowlanders evaluating the effect of acute exposure,
      acclimatization and re-exposure of high altitude on nocturnal breathing pattern.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Respiratory polygraphies will be performed in Santiago de Chile, 520 m, over the course of 3
      days. Participants will then travel by commercial airline (5 h flight) and by bus (3 h ride)
      to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile.
      Participants will stay there for the next 7 nights and respiratory polygraphies will be
      performed on night 1 and 6. They will be spend the days (6-8 h daily) at the telescope
      station at 5050 m while undergoing physiological testing. Daily transports from 2900 to 5050
      m will be by car (1 h ride, one way). After the first 8 day altitude sojourn participants
      will return to the Santiago area (520 m) for a 6 day recovery period.

      A second altitude sojourn with an identical schedule as the one described above and a final
      low altitude stay of 3 days will follow.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 4, 2016</start_date>
  <completion_date type="Actual">May 7, 2016</completion_date>
  <primary_completion_date type="Actual">May 7, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean nocturnal oxygen saturation measured by pulse oximetry</measure>
    <time_frame>first sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1</time_frame>
    <description>Change in mean nocturnal oxygen saturation over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea-/hypopnea index measured by respiratory polygraphy</measure>
    <time_frame>first sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1</time_frame>
    <description>Change in apnea-/hypopnea index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen desaturation index measured by respiratory polygraphy</measure>
    <time_frame>first sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1</time_frame>
    <description>Change in oxygen desaturation index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute mountain sickness measured by the Environmental Symptom questionnaire cerebral score (AMSc)</measure>
    <time_frame>first sojourn at 5050 m, day 2, 7; second sojourn at 5050 m, day 2,7; low altitude sojourn at 520 m, day 2</time_frame>
    <description>Incidence of acute mountain sickness (AMSc score &gt;= 0.7) over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Effect of High Altitude</condition>
  <arm_group>
    <arm_group_label>Altitude exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acute high altitude exposure followed by 8 day acclimatization and re-exposure after 6 days at low altitude</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Altitude exposure</intervention_name>
    <description>Altitude exposure</description>
    <arm_group_label>Altitude exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  born, raised and currently living &lt;800m

          -  No overnight stay at altitudes &gt;1500 m 4 weeks before the study

        Exclusion Criteria:

          -  Previous altitude intolerance to altitude &lt;3000 m

          -  Pregnancy

          -  Health impairment, which requires regular treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konrad E Bloch, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>March 31, 2016</study_first_submitted>
  <study_first_submitted_qc>March 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2016</study_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Altitude</keyword>
  <keyword>Nocturnal breathing pattern</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

